How a biotech revolution catapulted this East Bay company to a $100M IPO
This company has helped fuel the revolution in single-cell sequencing, which has accelerated discoveries in cancer, immunology and neuroscience.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
More News: Allergy & Immunology | Biotechnology | Brain | Cancer | Cancer & Oncology | Health Management | Neurology | Pharmaceuticals